LeMaitre Vascular Market Cap 2007-2019 | LMAT

LeMaitre Vascular market cap history and chart from 2007 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. LeMaitre Vascular market cap as of June 18, 2019 is $0.53B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.526B $0.106B
LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $147.168B 28.57
Medtronic (MDT) Ireland $131.379B 18.77
Stryker (SYK) United States $73.942B 26.39
Boston Scientific (BSX) United States $56.933B 27.29
Baxter (BAX) United States $41.099B 25.90
Zimmer Biomet Holdings (ZBH) United States $24.191B 15.54
Smith & Nephew SNATS (SNN) United Kingdom $18.938B 0.00
ResMed (RMD) United States $17.154B 32.78
Canopy Growth (CGC) Canada $14.483B 0.00
Bio-Rad Laboratories (BIO) United States $9.155B 48.53
Aurora Cannabis (ACB) Canada $7.667B 75.60
Insulet (PODD) United States $7.077B 515.65
Hill-Rom Holdings (HRC) United States $7.035B 21.33
Perrigo (PRGO) Ireland $5.966B 10.09
Haemonetics (HAE) United States $5.845B 47.71
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.968B 29.64
Hutchison China MediTech (HCM) China $3.770B 0.00
Neogen (NEOG) United States $3.289B 53.47
Agios Pharmaceuticals (AGIO) United States $3.048B 0.00
NuVasive (NUVA) United States $2.994B 24.45
National Vision Holdings (EYE) United States $2.410B 51.35
Quidel (QDEL) United States $2.275B 23.61
Aphria (APHA) $1.707B 0.00
Cardiovascular Systems (CSII) United States $1.521B 873.20
HEXO (HEXO) $1.425B 0.00
Phibro Animal Health (PAHC) United States $1.196B 17.92
AtriCure (ATRC) United States $1.169B 0.00
VAREX IMAGING (VREX) United States $1.109B 23.54
Lantheus Holdings (LNTH) United States $1.058B 28.10
OrganiGram Holdings (OGI) Canada $0.997B 0.00
NanoString Technologies (NSTG) United States $0.927B 0.00
PetIQ (PETQ) United States $0.900B 21.86
Quanterix (QTRX) United States $0.859B 0.00
Omeros (OMER) United States $0.823B 0.00
MacroGenics (MGNX) United States $0.817B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.748B 20.99
TG Therapeutics (TGTX) United States $0.684B 0.00
Cerus (CERS) United States $0.664B 0.00
Surmodics (SRDX) United States $0.569B 82.69
OraSure Technologies (OSUR) United States $0.540B 24.89
Meridian Bioscience (VIVO) United States $0.501B 15.31
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.368B 0.00
Evolus (EOLS) United States $0.362B 0.00
Vapotherm (VAPO) United States $0.357B 0.00
BioLife Solutions (BLFS) United States $0.335B 104.71
Utah Medical Products (UTMD) United States $0.318B 21.99
Zynex (ZYXI) United States $0.317B 32.73
Bovie Medical (APYX) United States $0.231B 0.00
Cytosorbents (CTSO) United States $0.203B 0.00
Owens & Minor (OMI) United States $0.182B 3.85
Chimerix (CMRX) United States $0.181B 0.00
Rockwell Medical (RMTI) United States $0.174B 0.00
Fonar (FONR) United States $0.136B 7.16
Female Health (VERU) United States $0.127B 0.00
BRAINSWAY LTD (BWAY) Israel $0.101B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
InfuSystems Holdings (INFU) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.092B 0.00
United-Guardian (UG) United States $0.088B 19.28
Neurotrope (NTRP) United States $0.087B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.061B 0.00
ImmuCell (ICCC) United States $0.048B 0.00
Trinity Biotech (TRIB) Ireland $0.038B 13.08
Senestech (SNES) United States $0.035B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Insys Therapeutics (INSY) United States $0.022B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Myomo (MYO) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.64